August 13, 2005 by TP Admin
Posted in
The FDA annouced a more restrictive distribution program for isotretinoin, a drug used to treat severe acne. The program is called iPledge, and its purpose is to prevent use of isotretinoin during pregnancy since the drug can cause birth defects.
Isotretinoin brand names are Accutane, Amnesteem, Claravis and Sotret.
More information is available at FDA News - August 12, 2005.
